Representational Image Getty Images
Though rare, if diagnosed early enough, Inborn Errors of Metabolism (IEM) can be cured quickly
Metabolic disorders are rare genetically determined disorders, affecting up to 1 in 1000 infants worldwide. More than 7000 Rare diseases have been reported globally and same is expected to be found in India. Genetic metabolic disorders contribute to about 10-15 per cent of them all. Although culturally we are a heterogeneous population and a melting pot of genetic diversity, our population is also known to indulge in consanguineous marriages and endogamy or marrying within communities, contributing somewhat to increasing the risk for acquiring Rare Diseases. One such rare group, commonly seen is a category of diseases called Inborn Errors of Metabolism (IEM).
ResearchAndMarkets.com’s offering.
“Global Genetic Testing Market Outlook 2022” provides a detailed analysis of the genetic testing market. The report also provides insight regarding the current and future perspectives of the market.
This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the restraints that can hinder the growth of the market, as well as rising opportunities which can provide new dimensions to the industry.
The advent of genetic tests has revolutionized the molecular diagnostics and cytogenetic industry. It is one of the most rapidly growing segments in the molecular diagnostics industry, which helps in delivering customized health services or personalized medicine. The share of genetic testing is incessantly increasing in the market. Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the majo